Genor Biopharma Holdings Limited (FRA:67N0)

Genor Biopharma Holdings Statistics

Total Valuation

FRA:67N0 has a market cap or net worth of EUR 196.48 million. The enterprise value is 74.35 million.

Market Cap	196.48M
Enterprise Value	74.35M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	524.75M
Shares Outstanding	n/a
Shares Change (YoY)	+2.19%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	2.74%
Owned by Institutions (%)	0.33%
Float	317.42M

Valuation Ratios

The trailing PE ratio is 57.16.

PE Ratio	57.16
Forward PE	n/a
PS Ratio	7.38
PB Ratio	1.50
P/TBV Ratio	1.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.97, with an EV/FCF ratio of -52.27.

EV / Earnings	21.63
EV / Sales	2.74
EV / EBITDA	12.97
EV / EBIT	19.63
EV / FCF	-52.27

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.00.

Current Ratio	4.93
Quick Ratio	4.93
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 2.56% and return on invested capital (ROIC) is 1.81%.

Return on Equity (ROE)	2.56%
Return on Assets (ROA)	1.50%
Return on Invested Capital (ROIC)	1.81%
Return on Capital Employed (ROCE)	2.81%
Revenue Per Employee	1.57M
Profits Per Employee	202,176
Employee Count	24
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:67N0 has paid 2.79 million in taxes.

Income Tax	2.79M
Effective Tax Rate	45.88%

Stock Price Statistics

The stock price has increased by +148.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+148.68%
50-Day Moving Average	0.37
200-Day Moving Average	0.32
Relative Strength Index (RSI)	51.26
Average Volume (20 Days)	153

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:67N0 had revenue of EUR 26.63 million and earned 3.44 million in profits. Earnings per share was 0.01.

Revenue	26.63M
Gross Profit	26.51M
Operating Income	3.72M
Pretax Income	6.09M
Net Income	3.44M
EBITDA	5.45M
EBIT	3.72M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 120.04 million in cash and 88,552 in debt, giving a net cash position of 119.95 million.

Cash & Cash Equivalents	120.04M
Total Debt	88,552
Net Cash	119.95M
Net Cash Per Share	n/a
Equity (Book Value)	130.59M
Book Value Per Share	0.25
Working Capital	98.25M

Cash Flow

In the last 12 months, operating cash flow was -1.30 million and capital expenditures -118,386, giving a free cash flow of -1.42 million.

Operating Cash Flow	-1.30M
Capital Expenditures	-118,386
Free Cash Flow	-1.42M
FCF Per Share	n/a

Margins

Gross margin is 99.56%, with operating and profit margins of 13.97% and 12.91%.

Gross Margin	99.56%
Operating Margin	13.97%
Pretax Margin	22.86%
Profit Margin	12.91%
EBITDA Margin	20.49%
EBIT Margin	13.97%
FCF Margin	n/a

Dividends & Yields

FRA:67N0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.19%
Shareholder Yield	-2.19%
Earnings Yield	1.75%
FCF Yield	-0.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:67N0 has an Altman Z-Score of -3.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.95
Piotroski F-Score	4